Buy, Sell or Fight: The New Calculus of Health System Growth in 2026

Bypaulgruensfelder
Becker’s Hospital Review May 8, 2026
Read Full Article →
AI-Generated Summary

Health systems in 2026 are applying a “buy, sell, or fight” calculus to market strategy — acquiring where they can build density, divesting where they’re subscale, and competing organically where they hold genuine advantages. CommonSpirit, Providence, and Community Health Systems are leading a wave of portfolio rationalization: CommonSpirit transferred Trinity Health System in Steubenville to UPMC and is selling North Dakota hospitals; Community Health Systems plans nine hospital divestitures across four states for more than $1.2 billion; Atrium Health announced a $2 billion combination with WakeMed in May 2026. The underlying driver is a shift from pure scale-seeking toward core-market focus and EBITDA durability. Scale alone is no longer the strategy.

Why It Matters

For PE-backed platforms and multi-site health networks, this consolidation wave creates both acquisition opportunities and competitive pressure. Understanding which systems are in sell mode — and where — is table stakes for deal sourcing and market entry decisions in 2026.

health system M&Aportfolio rationalizationhospital divestitures 2026EBITDA focusbuy sell fight frameworkCommonSpirit Providence CHSAtrium WakeMed

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

What three strategic options are health systems choosing between in 2026?

Becker’s Hospital Review outlines three dominant approaches: acquiring assets to build geographic density and market power, divesting subscale service lines or facilities that drain capital, and competing organically in markets where they hold a genuine structural advantage. Sophisticated systems are deploying all three simultaneously based on geography and service line.

When should a health system acquire versus grow organically?

Acquisitions make sense when a system can create geographic density, capture referral networks, or access talent that would take years to build independently. Organic competition is preferable when the system already holds a differentiated position in technology, outcomes, or patient loyalty that an acquisition would dilute rather than strengthen.

How are anticipated policy shifts influencing health system M&A timing in 2026?

Systems are accelerating deal timelines to close transactions and lock in market positions before policy uncertainty resolves. Anticipated Medicaid cuts and reimbursement changes are also prompting systems to divest service lines with heavy government payer exposure and redirect capital toward higher-margin ambulatory and specialty assets.

Similar Posts

  • CMS Proposes 2027 Physician Payment Overhaul: MIPS Sunset and ACO Expansion

    Bypaulgruensfelder

    CMS’s proposed CY 2027 Physician Fee Schedule rule would sunset traditional MIPS reporting in 2029, replace it with specialty-focused MIPS Value Pathways covering roughly 98% of specialties, and make Medicare ACOs easier to join and more rewarding. The Medicare Shared Savings Program — which paid $4.1 billion in shared savings to 75% of its 476 ACOs for 2024 while generating about $2.5 billion in net Medicare savings — would gain new-entrant financial incentives, more predictable spending benchmarks, and the option to reduce beneficiary cost-sharing starting April 2027. CMS also proposes recalibrating physician payment rates, introducing MIPS Core Measures in 2027, and closing an APM incentive loophole worth an estimated $2.38 billion over a decade.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Patient Portal Messages Have Surged 153% Since COVID, JAMA Study Finds

    Bypaulgruensfelder

    Patient-authored messages to providers have surged 153% since the COVID-19 pandemic, and a new JAMA study using Epic data finds the increase did not reduce telehealth or in-person visits. The authors conclude that patient messaging functions as an expansion of between-visit care rather than a substitute for it, and that the steady, gradual rise makes the trend likely to persist. Messaging was most common among female patients, patients aged 40 to 64, and those in affluent neighborhoods. The operational cost is significant: the AMA reports inbox overload is now a leading driver of physician burnout, with some physicians spending up to two hours nightly clearing their in-basket, and burnout conservatively costing health systems over $5 billion a year.